Skip to search formSkip to main contentSkip to account menu

RGH-4201

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

dihydrochandonium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
[Investigation of neuromuscular blocking agents at Richter Ltd].
Investigation of new neuromuscular blocking agents was started 30 years ago in Richter Ltd. This paper presents the results… 
1989
1989
Cardiovascular effects of vecuronium, atracurium, pancuronium, metocurine and RGH‐420 1 in dogs
The effect on the cardiovascular haemodynamic status of five neuromuscular blocking drugs, RGH‐4201, vecuronium, atracurium… 
1989
1989
In vitro comparison of the neuromuscular antinicotinic and intestinal antimuscarinic effects of different nondepolarizing muscle relaxants.
The postsynaptic antimuscarinic properties of different nondepolarizing muscle relaxants were compared with their postsynaptic… 
1981
1981
The pharmacology of a new short-acting, non-depolarising muscle relaxant steroid (RGH-4201).
The actions of a new steroid 3alpha-pyrrolidino-17alpha-methyl-17alpha-aza-D-homo-5alpha-androstane-dimethobromide (RGH-4201… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)